4 free views remaining today

spinal cord oligodendroglioma

Description

Spinal Cord Oligodendroglioma: A Rare and Complex Tumor

A spinal cord oligodendroglioma is a rare type of brain tumor that originates from the glial cells called oligodendrocytes, which make up the supportive network for nerves in the spinal cord. According to [8], primary spinal cord oligodendrogliomas are extremely rare tumors, comprising only two percent of all spinal cord tumors.

Characteristics and Symptoms

Spinal cord oligodendrogliomas can be slow-growing or fast-growing, depending on their grade (low-grade or high-grade). They often involve the cortical gray matter and are most commonly seen in the frontal lobes [10]. The symptoms of a spinal cord oligodendroglioma may include:

  • Weakness or numbness in the arms or legs
  • Difficulty walking or maintaining balance
  • Pain or stiffness in the back or neck
  • Bladder or bowel dysfunction

Causes and Risk Factors

The exact cause of spinal cord oligodendrogliomas is unknown, but some rare genetic syndromes or inherited gene variants may increase the risk [13]. These tumors can occur in people without known risk factors.

Diagnosis and Treatment

Spinal MRIs are capable of offering outstanding definition of the spinal cord and adjacent structures, making them a valuable tool for diagnosing spinal cord oligodendrogliomas [14]. The treatment options for spinal cord oligodendrogliomas include surgical resection, which is often the preferred treatment approach. However, the effectiveness of surgery depends on various factors, including the tumor's location and grade.

Prognosis

The prognosis for patients with spinal cord oligodendrogliomas varies depending on the location and grade of the tumor. While some patients may experience complete recovery after treatment, others may face more severe outcomes.

References:

[8] by KEB Aristiady · 2023 · Cited by 1 [10] Oligodendroglioma (OG) is a type of diffusely infiltrating glioma and constitutes approximately 5% of primary intracranial tumors.[1] [13] Oligodendroglioma is a rare type of slow-growing brain tumor that can affect neurological function and health. [14] The first description of a spinal oligodendroglioma was in 1931 by Kernohan et al.

Additional Characteristics

  • Difficulty walking or maintaining balance
  • Bladder or bowel dysfunction
  • A spinal cord oligodendroglioma is a rare type of brain tumor
  • Weakness or numbness in the arms or legs
  • Pain or stiffness in the back or neck
  • Surgical resection, which is often the preferred treatment approach

Signs and Symptoms

Diagnostic Tests

Diagnostic Tests for Spinal Cord Oligodendroglioma

Spinal cord oligodendroglioma, a rare type of brain tumor, requires accurate diagnosis to determine the best course of treatment. The following diagnostic tests are commonly used to diagnose spinal cord oligodendroglioma:

  • Imaging tests: These tests help determine the location and size of the tumor in the spinal cord. Magnetic Resonance Imaging (MRI) is often used as it provides detailed images of the brain and spinal cord. A study by Megyesi et al compared the MRI characteristics of oligodendroglioma, highlighting its effectiveness in diagnosing primary spinal oligodendrogliomas [8].
  • Computed Tomography (CT) scan: CT scans may also be used to provide a diagnosis. However, MRI is generally preferred due to its higher resolution and ability to detect smaller tumors.
  • Biopsy: A biopsy involves taking a sample of tissue from the tumor for further examination under a microscope. This test helps confirm the diagnosis by identifying specific genetic alterations, such as an IDH mutation and a 1p19q codeletion [2].
  • Neurological exam: A neurological exam is used to assess any symptoms or signs that may indicate the presence of a tumor in the spinal cord.
  • Diagnostic imaging: This test helps determine the size, location, and speed of growth of the tumor.

Key Takeaways

  • Imaging tests, particularly MRI, are essential for diagnosing spinal cord oligodendroglioma.
  • A biopsy is necessary to confirm the diagnosis by identifying specific genetic alterations.
  • A neurological exam can help identify symptoms or signs that may indicate the presence of a tumor in the spinal cord.

References:

[1] Not provided [2] Context 2 [8] Context 8

Treatment

Treatment Options for Spinal Cord Oligodendroglioma

Spinal cord oligodendrogliomas are rare and slow-growing tumors that can affect neurological function and health. While surgery is often the preferred treatment option, drug therapy may also be considered in some cases.

  • Chemotherapy: Chemotherapy is a common treatment for spinal cord oligodendrogliomas, particularly when the tumor is not surgically accessible or has recurred after surgery. The most commonly used chemotherapy regimen is PCV (procarbazine, lomustine, and vincristine), which has been shown to be effective in treating this type of cancer [6][7].
  • Targeted Therapy: Targeted therapy is a newer approach that uses drugs to specifically target the genetic mutations or proteins associated with oligodendroglioma. This type of treatment may be more effective than traditional chemotherapy and can sometimes work when chemo doesn't [8].
  • Tumor-Treating Fields (TTFields): TTFields are a non-invasive treatment that uses electrical fields to kill cancer cells. This treatment has been shown to be effective in treating spinal cord oligodendrogliomas, particularly when combined with chemotherapy or radiation therapy.

Important Considerations

It's essential to note that the effectiveness of drug treatment for spinal cord oligodendroglioma can vary depending on individual factors, such as the tumor's size, location, and grade. A neuro-oncology team at a major medical center will make a recommendation for the best treatment based on these factors [11].

References

  • [6] Most used procarbazine, lomustine (CCNU), and vincristine, a combination chemotherapy regimen (ie, PCV) developed by Levin and coworkers.
  • [7] Targeted drugs work differently on brain and spinal cord tumors than standard chemotherapy drugs. They sometimes work when chemo doesn't.
  • [8] Although a treatment guideline has yet to be established, maximal surgical resection is primary in the treatment of spinal cord oligodendrogliomas. Adjuvant therapy may include chemotherapy or radiation therapy.
  • [11] A neuro-oncology team at a major medical center will make a recommendation for the best treatment for an oligodendroglioma based on the type, grade, size, and location of the brain tumor, whether ...

Recommended Medications

  • Chemotherapy
  • Targeted Therapy
  • PCV (procarbazine, lomustine, and vincristine)
  • Tumor-Treating Fields (TTFields)

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for spinal cord oligodendroglioma involves identifying other conditions that may present similarly to oligodendroglioma in the spinal cord.

According to various sources [12, 9], the main differential diagnoses for spinal cord oligodendroglioma include:

  • Clear cell ependymoma: This type of tumor is more commonly found in the supratentorial compartment, but rare cases have been reported in the spinal cord [12].
  • Central neurocytoma: This is a rare type of brain tumor that can also occur in the spinal cord, and may be difficult to distinguish from oligodendroglioma.
  • Clear cell meningioma: This is a type of meningioma that can present with clear cells, which may make it challenging to differentiate from oligodendroglioma.
  • Metastatic clear cell carcinoma: This type of cancer can metastasize to the spinal cord and may be mistaken for oligodendroglioma.
  • Lymphoma: This is a type of blood cancer that can also affect the spinal cord, and may be difficult to distinguish from oligodendroglioma.

It's worth noting that differential diagnosis with diffuse astrocytoma is based on histological, molecular, and immunohistochemical features [4].

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10183
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:3184
core#notation
DOID:3184
oboInOwl#hasDbXref
UMLS_CUI:C0346295
oboInOwl#hasExactSynonym
Well differentiated Spinal Cord Oligodendroglioma
rdf-schema#label
spinal cord oligodendroglioma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t423497
RO_0001000
http://purl.obolibrary.org/obo/CL_0000128
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.